JP2897427B2 - 抗微生物活性を有する環状ヘキサペプチド化合物 - Google Patents

抗微生物活性を有する環状ヘキサペプチド化合物

Info

Publication number
JP2897427B2
JP2897427B2 JP8512472A JP51247296A JP2897427B2 JP 2897427 B2 JP2897427 B2 JP 2897427B2 JP 8512472 A JP8512472 A JP 8512472A JP 51247296 A JP51247296 A JP 51247296A JP 2897427 B2 JP2897427 B2 JP 2897427B2
Authority
JP
Japan
Prior art keywords
nmr
preparation example
mass
apci
kbr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP8512472A
Other languages
English (en)
Japanese (ja)
Other versions
JPH10507174A (ja
Inventor
秀徳 大木
昌紀 冨島
山田　　明
寿 高杉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26305774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2897427(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9420425A external-priority patent/GB9420425D0/en
Priority claimed from GBGB9508745.8A external-priority patent/GB9508745D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPH10507174A publication Critical patent/JPH10507174A/ja
Application granted granted Critical
Publication of JP2897427B2 publication Critical patent/JP2897427B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP8512472A 1994-10-07 1995-09-29 抗微生物活性を有する環状ヘキサペプチド化合物 Expired - Lifetime JP2897427B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9420425A GB9420425D0 (en) 1994-10-07 1994-10-07 New compound
GB9420425.2 1994-10-07
GB9508745.8 1995-04-28
GBGB9508745.8A GB9508745D0 (en) 1995-04-28 1995-04-28 New compound
PCT/JP1995/001983 WO1996011210A1 (en) 1994-10-07 1995-09-29 Cyclic hexapeptides having antibiotic activity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP13675698A Division JP3518665B2 (ja) 1994-10-07 1998-05-19 抗微生物活性を有する新規環状ヘキサペプチド化合物

Publications (2)

Publication Number Publication Date
JPH10507174A JPH10507174A (ja) 1998-07-14
JP2897427B2 true JP2897427B2 (ja) 1999-05-31

Family

ID=26305774

Family Applications (2)

Application Number Title Priority Date Filing Date
JP8512472A Expired - Lifetime JP2897427B2 (ja) 1994-10-07 1995-09-29 抗微生物活性を有する環状ヘキサペプチド化合物
JP13675698A Expired - Lifetime JP3518665B2 (ja) 1994-10-07 1998-05-19 抗微生物活性を有する新規環状ヘキサペプチド化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP13675698A Expired - Lifetime JP3518665B2 (ja) 1994-10-07 1998-05-19 抗微生物活性を有する新規環状ヘキサペプチド化合物

Country Status (26)

Country Link
US (2) US6107458A (cg-RX-API-DMAC7.html)
EP (1) EP0788511B1 (cg-RX-API-DMAC7.html)
JP (2) JP2897427B2 (cg-RX-API-DMAC7.html)
KR (1) KR100353303B1 (cg-RX-API-DMAC7.html)
CN (1) CN1203089C (cg-RX-API-DMAC7.html)
AR (1) AR041770A1 (cg-RX-API-DMAC7.html)
AT (1) ATE229541T1 (cg-RX-API-DMAC7.html)
AU (1) AU696949B2 (cg-RX-API-DMAC7.html)
BR (2) BR9504791B1 (cg-RX-API-DMAC7.html)
CA (1) CA2202058C (cg-RX-API-DMAC7.html)
DE (2) DE122008000025I2 (cg-RX-API-DMAC7.html)
DK (1) DK0788511T3 (cg-RX-API-DMAC7.html)
ES (1) ES2187575T3 (cg-RX-API-DMAC7.html)
FI (1) FI119988B (cg-RX-API-DMAC7.html)
FR (1) FR08C0028I2 (cg-RX-API-DMAC7.html)
HU (1) HU228151B1 (cg-RX-API-DMAC7.html)
IL (1) IL115484A (cg-RX-API-DMAC7.html)
LU (1) LU91452I2 (cg-RX-API-DMAC7.html)
MX (1) MX9702531A (cg-RX-API-DMAC7.html)
NL (1) NL300352I2 (cg-RX-API-DMAC7.html)
NO (2) NO328483B1 (cg-RX-API-DMAC7.html)
OA (1) OA10475A (cg-RX-API-DMAC7.html)
PT (1) PT788511E (cg-RX-API-DMAC7.html)
RU (1) RU2165423C2 (cg-RX-API-DMAC7.html)
TR (1) TR199501229A2 (cg-RX-API-DMAC7.html)
WO (1) WO1996011210A1 (cg-RX-API-DMAC7.html)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696084A (en) * 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
US6291680B1 (en) * 1997-06-18 2001-09-18 Fujisawa Pharmaceutical Co., Ltd. Production process
CA2320416A1 (en) * 1998-02-09 1999-08-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AU756792B2 (en) * 1998-02-09 2003-01-23 Fujisawa Pharmaceutical Co., Ltd. New compound
ES2251976T3 (es) * 1999-02-11 2006-05-16 Emisphere Technologies, Inc. Compuestos y composiciones de oxadiazol para aportar agentes activos.
US7084279B1 (en) * 1999-02-11 2006-08-01 Emisphere Technologies Inc. Oxadiazole compounds and compositions for delivering active agents
AUPP999799A0 (en) * 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPQ066399A0 (en) * 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
CA2380176A1 (en) 1999-07-27 2001-02-01 Aventis Pharma Deutschland Gmbh Novel cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical
AUPQ462399A0 (en) * 1999-12-13 2000-01-13 Fujisawa Pharmaceutical Co., Ltd. New use
TWI250992B (en) 2000-02-21 2006-03-11 Astellas Pharma Inc Polypeptide compounds for the prophylactic and/or therapeutic treatment of infectious diseases caused by pathogenic microorganisms
ES2191516B1 (es) * 2000-07-28 2005-01-01 Consejo Superior De Investigaciones Cientificas Antibioticos antifungicos de naturaleza peptidica inhibidores de la germinacion y el crecimiento de hongos fitopatogenos.
AUPQ938700A0 (en) * 2000-08-14 2000-09-07 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
ATE452637T1 (de) 2001-01-29 2010-01-15 Shionogi & Co Arzneipräparat, das als wirkstoff 5-methyl-1- phenyl-2-(1h)-pyridon enthält
JP2005053782A (ja) * 2001-08-31 2005-03-03 Fujisawa Pharmaceut Co Ltd 環状リポペプチド化合物の新規結晶
AU2003217676B2 (en) 2002-02-22 2009-06-11 Takeda Pharmaceutical Company Limited Active agent delivery systems and methods for protecting and administering active agents
US7199248B2 (en) 2002-08-08 2007-04-03 Astellas Pharma Inc. Process
AU2003903205A0 (en) * 2003-06-23 2003-07-10 Fujisawa Pharmaceutical Co., Ltd. New compound
WO2005018743A1 (en) * 2003-07-22 2005-03-03 Theravance, Inc. Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent
AU2004273029A1 (en) * 2003-09-05 2005-03-24 Merck & Co., Inc. Stationary phases and a purification process using the stationary phases
WO2005028438A1 (ja) * 2003-09-22 2005-03-31 Banyu Pharmaceutical Co., Ltd. 新規ピペリジン誘導体
US7476673B2 (en) * 2003-12-30 2009-01-13 Allergan, Inc. Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors
US20050261365A1 (en) * 2004-05-20 2005-11-24 The Scripps Research Institute Transthyretin stabilization
CN101084212A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途
BRPI0515482A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos e seus usos como agentes terapêuticos
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
AR051092A1 (es) 2004-09-20 2006-12-20 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa
MX2007003332A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
TW200626155A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
JP5043668B2 (ja) 2004-09-20 2012-10-10 ゼノン・ファーマシューティカルズ・インコーポレイテッド 複素環誘導体および治療薬としてのそれらの使用
KR20070067165A (ko) * 2004-10-13 2007-06-27 피티씨 테라퓨틱스, 인크. 넌센스 변이 억제용 화합물, 및 이의 사용 방법
JP2009513563A (ja) 2005-06-03 2009-04-02 ゼノン・ファーマシューティカルズ・インコーポレイテッド ヒトのステアロイル−ＣｏＡデサチュラーゼ阻害剤としてのアミノチアゾール誘導体
WO2007043401A1 (ja) * 2005-10-07 2007-04-19 Kissei Pharmaceutical Co., Ltd. 含窒素複素環化合物およびそれを含有する医薬組成物
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
US8853392B2 (en) 2007-06-03 2014-10-07 Vanderbilt University Benzamide mGluR5 positive allosteric modulators and methods of making and using same
PL2786992T3 (pl) 2007-08-13 2018-04-30 Monsanto Technology Llc Kompozycje i sposoby zwalczania nicieni
AU2008319977A1 (en) * 2007-10-29 2009-05-07 Astellas Pharma Inc. Polypeptide compound
US8034806B2 (en) 2007-11-02 2011-10-11 Vanderbilt University Bicyclic mGluR5 positive allosteric modulators and methods of making and using same
CA2729212C (en) * 2008-06-24 2014-04-01 Irm Llc Compounds and methods for modulating g protein-coupled receptors
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
BR112013023531A2 (pt) * 2011-04-04 2016-12-06 Xellia Pharmaceuticals Aps processo de um único vaso para a fabricação de micafungina ou de um sal desta
BR112013026420A2 (pt) 2011-04-20 2020-11-03 Xellia Pharmaceuticals Aps método de produção de um sal de micafungina farmaceuticamente aceitável
CN102775476B (zh) 2011-05-12 2015-01-07 上海天伟生物制药有限公司 一种米卡芬净钠盐的制备方法
EP2709609B1 (en) 2011-05-17 2017-10-04 Shionogi & Co., Ltd. Heterocyclic compounds
EP2763971B1 (en) 2011-09-09 2016-06-08 Sandoz AG Preparation of micafungin intermediates
CN102659930B (zh) 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
CN102627689B (zh) 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN102627688B (zh) 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
EP3150621A4 (en) * 2014-05-29 2017-12-27 Shanghai Techwell Biopharmaceutical Co., Ltd Composition of cyclic peptide compound, preparation method for same, and uses thereof
CN104861044B (zh) * 2014-05-29 2019-03-01 上海天伟生物制药有限公司 一种环肽类化合物的溶剂合物及其制备方法和用途
WO2016056023A2 (en) * 2014-10-07 2016-04-14 Alaparthi Lakshmi Prasad Intermediates and processes to prepare micafungin
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
FI3554474T3 (fi) 2016-12-16 2024-02-21 Baxter Int Mikafungiinikoostumuksia
EP3485873A1 (en) 2017-11-17 2019-05-22 Cadila Healthcare Limited Stable pharmaceutical injectable compositions of micafungin
CN113087775B (zh) * 2018-05-31 2022-07-08 杭州中美华东制药有限公司 米卡芬净钠新晶型ii及其制备方法
WO2020013116A1 (ja) * 2018-07-10 2020-01-16 京都薬品工業株式会社 Ｐｔｐ－１ｂ阻害剤およびその用途
CN110734408A (zh) * 2019-10-22 2020-01-31 重庆康乐制药有限公司 一种米卡芬净类衍生物侧链中间体的制备方法
CN115785226A (zh) * 2021-09-09 2023-03-14 上海天伟生物制药有限公司 一种棘白菌素药物杂质及其制备、纯化方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1574603A1 (ru) * 1988-08-11 1990-06-30 Ивановский Химико-Технологический Институт Способ получени мезо-тетраарилоктаметилпорфиринов
FI912873A7 (fi) * 1990-06-18 1991-12-19 Fujisawa Pharmaceutical Co Uusi polypeptidiyhdiste ja menetelmä sen valmistamiseksi
MY136593A (en) * 1992-03-19 2008-10-31 Lilly Co Eli Cyclic peptide antifungal agents and process for preparation thereof

Also Published As

Publication number Publication date
CA2202058C (en) 2007-11-06
FR08C0028I1 (cg-RX-API-DMAC7.html) 2008-08-15
CN1168675A (zh) 1997-12-24
LU91452I2 (fr) 2008-08-04
HUT77736A (hu) 1998-07-28
NO971544D0 (no) 1997-04-04
KR970707150A (ko) 1997-12-01
JPH10507174A (ja) 1998-07-14
NO971544L (no) 1997-06-04
FI971397L (fi) 1997-05-27
ES2187575T3 (es) 2003-06-16
IL115484A (en) 2000-07-16
KR100353303B1 (ko) 2003-01-15
NL300352I1 (nl) 2008-08-01
NO2010016I2 (no) 2011-10-17
EP0788511A1 (en) 1997-08-13
DE122008000025I1 (de) 2008-08-21
NO2010016I1 (no) 2010-08-16
DE122008000025I2 (de) 2011-02-17
JP3518665B2 (ja) 2004-04-12
PT788511E (pt) 2003-04-30
ATE229541T1 (de) 2002-12-15
AU696949B2 (en) 1998-09-24
DE69529172D1 (de) 2003-01-23
US6107458A (en) 2000-08-22
JPH10324695A (ja) 1998-12-08
NO328483B1 (no) 2010-03-01
NL300352I2 (nl) 2008-11-03
EP0788511B1 (en) 2002-12-11
DK0788511T3 (da) 2003-03-31
BR9504791B1 (pt) 2010-10-05
CA2202058A1 (en) 1996-04-18
FI119988B (fi) 2009-05-29
BR9504791A (pt) 1996-10-22
US6265536B1 (en) 2001-07-24
CN1203089C (zh) 2005-05-25
TR199501229A2 (tr) 1996-07-21
MX9702531A (es) 1997-06-28
OA10475A (en) 2002-04-08
HK1004136A1 (en) 1998-11-20
IL115484A0 (en) 1996-01-19
RU2165423C2 (ru) 2001-04-20
DE69529172T2 (de) 2003-04-17
FR08C0028I2 (cg-RX-API-DMAC7.html) 2009-11-20
FI971397A0 (fi) 1997-04-04
HU228151B1 (en) 2012-12-28
AU3578095A (en) 1996-05-02
BRPI9504791B8 (pt) 2019-12-31
AR041770A1 (es) 2005-06-01
WO1996011210A1 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
JP2897427B2 (ja) 抗微生物活性を有する環状ヘキサペプチド化合物
US6232290B1 (en) Cyclic hexapeptides with antimicrobial activity
EP0644199B1 (en) Cyclic antimicrobial peptides and preparation thereof
JP2002226500A (ja) 環状ペプチド抗真菌剤およびその製法
EP2628738B1 (en) Heterocyclic substituted pyridine derivatives and antifungal agent containing same
BR112014013963B1 (pt) Compostos inibidores de metaloenzimas, composições compreendendo os ditos compostos, uso terapêutico dos mesmos e métodos para inibir a atividade de metaloenzimas e para tratar ou prevenir o crescimento de fungos em plantas
TW438773B (en) Indole derivatives
JP2000505471A (ja) フィブリノーゲン受容体拮抗物質
KR20140063509A (ko) 과오종 종양 세포의 억제 방법
TW425392B (en) Oxazolidinonecarboxylic acid derivatives for use as adhesion receptor antagonists preparation process therefor and pharmaceutical composition comprising the same
JPH07330733A (ja) レトロウイルスのプロテアーゼインヒビター
JP3906690B2 (ja) 環状ヘキサペプチド誘導体
JPH09508363A (ja) アミノ酸誘導体およびそのホスホリパーゼａ▲下２▼阻害剤としての用途
EP0941236A1 (en) Cyclohexapeptides having antimicrobial activity
CN107325052B (zh) 一类具有抗癌活性的咪唑酯类化合物及其衍生物
WO1995000536A1 (en) Peptide compounds
JPH11505208A (ja) 環状ペプチド化合物およびそれらの誘導体
WO2003068807A2 (en) Echinocandin cyclic peptide derivatives
WO2001005814A1 (en) Pseudomycin n-acyl side-chain analogs
JP2003533506A (ja) Ｎ−置換ペプチジルニトリル
JP2002502239A (ja) 新規化合物
CN108822127B (zh) 4-羟亚胺基噻吩并[2,3-b]噻喃-2-甲酰胺类化合物及其用途
AU708306B2 (en) Esters and amides as PLA2 inhibitors
CN108822125A (zh) 1-(噻吩并[2,3-b]噻喃甲酰基)-4-脂肪烃基哌嗪类化合物及其医药用途
JPH09501149A (ja) ペプチド化合物

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
R151 Written notification of patent or utility model registration

Ref document number: 2897427

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

R153 Grant of patent term extension

Free format text: JAPANESE INTERMEDIATE CODE: R153

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20200312

Year of fee payment: 21

R153 Grant of patent term extension

Free format text: JAPANESE INTERMEDIATE CODE: R153

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20200312

Year of fee payment: 21

R154 Certificate of patent or utility model (reissue)

Free format text: JAPANESE INTERMEDIATE CODE: R154

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20200312

Year of fee payment: 21

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20200312

Year of fee payment: 21

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250